InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Terrillion Scott, Executive. Insider active across 1 company, notably Cara Therapeutics, Inc.. Cumulatively, 18 reports have been recorded. Split: 0 buy · 12 sells. Total volume traded: €191k. History available since 24 August 2021. The latest transaction was filed on 28 February 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations18 total
163 shares@ US$4.760.4% of flowCommon StockSEC:0001415889-25-006575:0
2,753 shares@ US$0.831.1% of flowCommon StockSEC:0001415889-24-010569:0
3,293 shares@ US$0.891.4% of flowCommon StockSEC:0001415889-24-006282:0
7,770 shares@ US$0.532.0% of flowCommon StockSEC:0001415889-24-003408:0
13,500 shares0Common StockSEC:0001415889-24-002536:0
2,483 shares@ US$3.514.2% of flowCommon StockSEC:0001209191-23-039884:0
2,481 shares@ US$4.915.8% of flowCommon StockSEC:0001209191-23-023607:0
6,256 shares@ US$9.7130.0% of flowCommon StockSEC:0001209191-23-016790:0
2,561 shares@ US$11.2714.2% of flowCommon StockSEC:0001209191-22-062628:0
1,642 shares@ US$11.9122.6% of flowCommon StockSEC:0001209191-22-023249:0
1,787 shares@ US$11.3823.4% of flowCommon StockSEC:0001209191-22-016431:0
20,000 shares0Common StockSEC:0001209191-22-013994:0
11,495 shares0Common StockSEC:0001209191-21-070805
11,495 shares0Common StockSEC:0001209191-21-070805:0
1,759 shares@ US$14.2027.0% of flowCommon StockSEC:0001209191-21-054304:0
1,759 shares@ US$14.2011.1% of flowCommon StockSEC:0001209191-21-054304
5,334 shares0Common StockSEC:0001209191-21-053537
5,334 shares0Common StockSEC:0001209191-21-053537:0
18 of 18 declarations
About Terrillion Scott
Scott Terrillion is Secretary, Chief Compliance Officer, and General Counsel of Cara Therapeutics, Inc. In this role, he oversees the company's legal and compliance matters. Terrillion brings significant expertise in the legal field, contributing to process optimization and risk management. His role is essential in ensuring compliance and good governance at Cara Therapeutics.
